IMAX Stock Imax (IMAX, $36.88) was a top quarterly gainer, rising +28.41%

GET DAILY SIGNALS

Get AI intraday signals

IMAX - Imax Corp

Loading...

Price: $36.88

Daily change: +$0.85 (+2.36%)

Daily volume: 1.2M

3-month price change: +$8.16 (+28.41%)

Capitalization: $2B

Industry: Movies/Entertainment

Imax (IMAX, $36.88) was one of top quarterly gainers, jumping +2 to $36.88 per share. A.I.dvisor analyzed 96 stocks in the Movies/Entertainment Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.

Aroon Indicator for IMAX shows an upward move is likely

IMAX's Aroon Indicator triggered a bullish signal on November 20, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 233 similar instances where the Aroon Indicator showed a similar pattern. In of the 233 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 23, 2025. You may want to consider a long position or call options on IMAX as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMAX just turned positive on November 05, 2025. Looking at past instances where IMAX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMAX advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IMAX moved out of overbought territory on November 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where IMAX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMAX broke above its upper Bollinger Band on November 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.675) is normal, around the industry mean (20.445). P/E Ratio (51.944) is within average values for comparable stocks, (78.156). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (11.364). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (5.379) is also within normal values, averaging (11.164).